Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

J&J inks $1bn deal with US for coronavirus vaccine

J&J inks $1bn deal with US for coronavirus vaccine

Novavax and AstraZeneca/Oxford University.

US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine

US secures 100 million doses of Sanofi/GSK’s COVID-19 vaccine Both companies are also in talks with EU for access to candidate

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca. .

AstraZeneca escapes pandemic impact as new drugs bolster revenues

AstraZeneca escapes pandemic impact as new drugs bolster revenues Earnings climbed above expectations in the second quarter. British drugmaker AstraZeneca escaped the negative impact of the COVID-19 pandemic in its second quarter results, posting an impressive increase in its

Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial

Boehringer/Lilly's Jardiance hits the mark in pivotal heart failure trial This includes AstraZeneca’s Farxiga (dapagliflozin), which became the first drug in the SGLT2 inhibitor class to be approved in the US to reduce the chance of hospitalisations, in adults with

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics